PRI-002, Oral Therapy Candidate for Alzheimer’s, Deemed Safe in Phase 1 Trial

Home / Alzheimer's / PRI-002, Oral Therapy Candidate for Alzheimer’s, Deemed Safe in Phase 1 Trial